11 July 2018 - The top Democrat on the Senate Finance Committee is demanding details on an agreement between President Trump and drug company Pfizer to temporarily hold off on drug price increases.

“Secret, sweetheart arrangements with pharmaceutical companies are exactly why America’s drug pricing system is broken,” said Senator Ron Wyden.

Pfizer announced Tuesday evening it would defer previously announced price increases on 100 drugs following "an extensive discussion" with Trump to give the administration more time to work on its plan to lower costs.

Read The Hill article